Portfolio
IntraLase
Medical device company that developed an automated procedure for laser vision correction, procedure known as "IntraLasik" or "Bladeless Lasik"(1998)
CardioGene Therapeutics
CardioGene is focused on the development of novel gene therapy products for the treatment of cardiovascular disease (Formerly Genocor, Inc.)(1997)
Michigan Aerospace, Inc.
Light Detection and Ranging (LIDAR) and related optical systems for atmospheric measurement(1997)
Biotherapies, Inc.
Commercializing Mammastatin Serum Assay technology used to screen breast cancer risk(1996)
IDUN Pharmaceuticals, Inc.
Therapeutic applications focused on inhibiting caspase activity as treatments for liver disease and inflammation(1994)
Targeted Genetics
Molecular medicines for disease detection and prevention (Formerly Genevo)(1994)
Vetgen, Inc.
Research and genetic disease detection services for all purebred animals(1994)
GlycoGen
Developing immunomodulatory & anti-inflammatory therapeutics based on cell adhesion technology(1992)
K-Space Associates, Inc.
Optical imaging using in-situ thin-film and wafer characterization technologies(1992)
SoloHill Engineering, Inc.
Microcarriers and protocols for cell culture applications(1992)
MC3
MC3 Cardiopulmonary, located in Dexter, was founded in 1991 by Robert Bartlett, M.D., a pioneering University of Michigan surgeon, and Scott Merz, PhD, to develop Extracorporeal Membrane Oxygenation (ECMO) technology for patients who would otherwise succumb to heart and lung disease.(1991)
3D Static Strength Prediction Program
The 3D Static Strength Prediction Program™ (3D SSPP) is an effective way to analyze the biomechanics and safety of manual materials handling. The software allows the user to predict static strength requirements for common manual tasks like lifts, presses, pushes, and pulls.(1990)